1.Practical bottleneck: activity is only the start—projects more often stall on solubility, exposure, and metabolism
1. In drug discovery and functional-molecule R&D, obtaining an “it binds/it works” activity signal is often only the starting point. Projects more commonly get stuck on properties and developability: insufficient solubility, an overly narrow physicochemical window, the difficulty of balancing permeability with in vivo exposure, selectivity that fluctuates across systems/conditions, and metabolic/in vivo behavior that is hard to predict or hard to converge.
2. Accordingly, optimization often shifts from “add another functional group to boost potency” toward “swap in a more suitable scaffold module (scaffold hop) to widen the property window”—and nitrogen heterocycles are among the most frequently used tools. Structural surveys of FDA-approved small-molecule drugs show that a substantial fraction (often reported around ~60%, with variation depending on definitions and counting rules) contain at least one nitrogen heterocycle, which also helps explain why these motifs are repeatedly treated as transferable, series-friendly “structural module libraries.”
3. In parallel, retrospective studies often use indices such as Fsp³ (saturation/three-dimensionality) to describe “more 3D, more saturated, more stereocenter-rich” molecular features, and have observed statistical correlations between such features and translation from discovery to drugs, as well as trends in properties such as solubility. Note that higher Fsp³ does not mean “automatically better.” Rather, it prompts you to check whether a molecule is overly planar or insufficiently saturated. In the end, you still need to close the loop on actionable variables—microstate distribution (pKa), logD, PSA, clearance routes, and so on.
4. Within this framework, piperidine and its “one-size-up/homologous” saturated nitrogen rings (e.g., homopiperidine/azepane) function like a practical set of “structural tuning knobs.” By adjusting ring size and conformational behavior, the form of the nitrogen center (free amine vs salt vs amide, etc.), and scaffold rigidity (more flexible vs more rigid), you redistribute 3D shape and charge state—improving the odds of bringing the mutually constrained “solubility–permeability–metabolism” window into a more workable range.
2.Core concepts: what are “heterocycle building blocks” and “homopiperidines”?
2.1 What is a “heterocycle building block” (heterocycle building block)?
A “heterocycle building block” can be understood as a ring scaffold that can be repeatedly reused in molecular design. It is not necessarily a drug on its own, but it reliably brings a predictable set of 3D shape and physicochemical characteristics (e.g., basicity/salt-forming ability, hydrogen-bonding behavior, conformational flexibility/rigidity). That makes it especially suitable for systematic series comparisons and property tuning. In other words, its value is more about being a reusable, comparable module than about being an “end-point molecule” by itself.
2.2 What core scaffold does “homopiperidine” refer to?
“Homopiperidine” refers to homopiperidine / azepane: a seven-membered, saturated, mono-nitrogen ring (= 1-azacycloheptane, often written as “azacycloheptane”). Across databases and supplier listings, it also appears under multiple aliases, such as hexamethyleneimine (HMI), perhydroazepine, and older spellings like hexahydro-1H-azepine / hexahydroazepine (often used to refer to the same saturated core scaffold).
2.3 Quick terminology table
Term | Corresponding structure/meaning | Key takeaway |
Homopiperidine / Azepane | Seven-membered saturated N-heterocycle (one N) | Keywords: seven-membered + saturated + one nitrogen; commonly used as a “ring-size control” vs piperidine. |
Piperidine | Six-membered saturated N-heterocycle (one N) | Keywords: six-membered control; same amine center, but different ring size can change conformation and substituent exit vectors (a frequent head-to-head comparator in selection). |
Hexamethyleneimine / 1-Azacycloheptane, etc. | Common aliases of homopiperidine/azepane | Mostly different names for the same core scaffold, often varying by database/supplier. |
3.Structural features: how three “structural knobs” determine properties and use cases
Structural knob (what you changed) | Property variable directly affected | Typical use in R&D (how it’s applied) |
Ring size & conformational freedom: seven-membered saturated ring | 3D projection, substituent “exit vectors,” pocket-fit geometry | Scaffold hop: keep the amine center, change the spatial trajectory |
Nitrogen-center form: N–H / N-substituted / amidation / quaternization | Charge state & salt window, H-bond donor/acceptor pattern, solubility–distribution balance | Tune solubility/exposure; alter binding mode and nonspecific interactions |
Rigidity & stereochemical “3D locking”: substitution, fused/spiro/bridged systems | Conformational uniformity, selectivity trends, magnitude of property fluctuation | “Lock” conformations to improve reproducibility; make SAR more interpretable as a series |
3.1 Ring size: from 6 → 7
When you replace piperidine with a seven-membered saturated nitrogen ring, the most common change is not simply “one extra carbon,” but a larger set of accessible conformations and a higher likelihood that substituent directionality (exit vectors) will shift. Therefore, under the premise of “the same amine center,” you may obtain a different pocket-fit mode and a different geometric relationship—this is a core value of scaffold hopping: without stacking on additional functional groups, you can systematically change a molecule’s 3D projection and substituent vectors while preserving the core interaction site.
Note: The value of 6→7 is more about “spatial trajectory/conformation” than about “pKa is completely transformed.” What truly widens the usable property window is often the combined effect of conformation + substitution + microstate distribution.
3.2 Nitrogen-center form: it sets charge state and hydrogen-bonding, thereby shaping solubility and exposure
Saturated nitrogen rings are widely used because they make key properties more controllable and adjustable in stepwise fashion—most notably charge state/salt formation and hydrogen-bonding features:
1. N–H vs N-substitution: affects whether the neutral form behaves as a hydrogen-bond donor (HBD, hydrogen-bond donor). More importantly, it changes the protonation fraction (microstate distribution), thereby coupling the HBD/HBA (donor/acceptor) pattern to the solubility–distribution (logD) balance.
2. Salt formation: often one of the most direct ways to improve aqueous solubility and formulation operability (salt form must be considered together with pH conditions).
3. Amidation: typically reduces basicity and protonatability substantially, lowering the fraction of positively charged species and shifting the distribution/permeability window in a systematic way.
4. Quaternization: fixes the nitrogen as permanently positively charged, commonly used when strong ionic interactions or a permanent-charge feature is desired.
3.3 Make conformations more “single-state”: stabilize SAR and make it more interpretable
If the same scaffold frequently switches among multiple conformations, activity and ADME properties are more likely to fluctuate within a series. In R&D, teams often “lock” conformations by introducing fused/spiro/bridged systems, or by adding substitution and chirality at key positions—reducing the number of accessible states so that SAR becomes more stable and easier to rationalize.
Caution: more rigidity is not always better. It may improve selectivity and enforce more consistent binding geometry, but it can also hurt solubility and limit exposure. A more accurate view is that rigidification is a tool to improve controllability, and it must be balanced against solubility, permeability, and metabolic windows.
4.Classification: distinguish homopiperidine-type building blocks along three dimensions
Classification axis | Key criteria (what structural information to check) | Typical sub-classes |
A. Scaffold architecture (3D shape & rigidity) | Determines the molecule’s 3D projection/occupancy and conformational freedom: more flexible vs more conformationally locked | Monocyclic azepane (homopiperidine core); fused seven-membered amines (more rigid, more directional); spiro/bridged seven-membered amines (strong conformational locking, more fixed exit vectors) |
B. Nitrogen-center form (charge state & H-bond features) | Determines protonatability/salt-forming ability, whether it is an H-bond donor, and the tendency for nonspecific interactions | N–H (free amine); N-substituted (e.g., N-alkyl); amide/lactam (significantly lowers basicity); quaternary ammonium salts (permanent positive charge) |
C. Ring substitution (exit vectors & stereochemical 3D-ness) | Determines substituent direction/pocket fit and SAR interpretability; also determines whether enantiomer separation is needed | Unsubstituted / mono-substituted / multi-substituted; racemate vs single enantiomer; (supplement) substitution at key positions is often used to lock conformations / tune exit vectors |
Practical notes:
1. Protecting groups (N-Boc, Cbz, Fmoc, etc.): primarily affect synthetic operability and downstream derivatization routes; they are not equivalent to the final pharmacologically relevant form.
2. Physical form (free base vs salt, e.g., HCl salt): directly affects solubility, weighing/handling, stability, and formulation evaluation, and often requires dedicated head-to-head comparisons.
5.Application quick guide: what three classes of problems are homopiperidines commonly used to solve in lead optimization?
R&D bottleneck | Which structural class to adjust first (Sections 3–4) | Common design moves (how to build comparisons) | Signals to prioritize |
A. Solubility / salt form / charge state is unstable: pH shifts cause state fluctuation; exposure is hard to establish | Nitrogen-center form (charge/H-bonding) + salt form (free base vs salt) | Build a small series on the same core: N–H (salt-forming) ↔ N-substituted; when needed, add “stronger” form controls: amidation (lower protonatability) or quaternization (permanent positive charge, if the design calls for it) | Solubility and dissolution; form/solubility trends across pH; logD/distribution changes; in vivo exposure (if available) |
B. Need to “change the spatial trajectory”: don’t want to lose the amine center, but pocket fit/sterics are suboptimal | Scaffold architecture (ring size/conformation) + ring substitution (exit vectors) | Do scaffold-swap controls: piperidine (6-membered) ↔ homopiperidine/azepane (7-membered); under similar functional groups and substitution load, compare exit-vector changes; if needed, fine-tune substitution positions to test the pocket-fit hypothesis | Whether potency/selectivity improve together; whether SAR becomes more continuous; whether sensitivity to key substituents matches expectation (suggesting improved geometric fit) |
C. SAR is too “scattered,” data are noisy: results fluctuate within a series; rules are hard to summarize | Rigidity & stereochemical 3D-ness (conformational locking/state convergence) | Use fused/spiro/bridged motifs to reduce degrees of freedom; introduce substitution/chiral centers at key positions; compare racemate vs single enantiomer (where applicable) | Whether reproducibility/batch-to-batch variation decreases; whether the comparison series becomes more “monotonic and interpretable”; whether selectivity and metabolism/exposure become more predictable |
6.Product navigation for homopiperidine / azacycloheptane (Azepane): quickly pick the right table (1–3) by “the R&D job to be done”
Research task / experimental need | Which table to consult | Why this table first |
Need a coupling-ready seven-membered N-heterocycle carboxylic-acid module (for amidation / annulation / fragment attachment) | Table 1 | Table 1 groups Boc/Cbz-protected carboxylic acids together, including matched 3-carboxy vs 4-carboxy position controls—ideal for coupling under protection, then deprotection/salt optimization. |
Need positional controls (3-position vs 4-position) to compare how conformation/3D occupancy impacts SAR | Table 1 | Table 1 provides a matched “entry set”: 3-CO₂H vs 4-CO₂H, 3-hydroxymethyl vs 4-hydroxymethyl, plus 4-hydroxy / chiral 4S-hydroxy—better suited for systematic structure-control series. |
Need a hydroxy/hydroxymethyl handle for halogenation / sulfonate ester formation / etherification / oxidation, to build linkers or tune polarity | Table 1 | Table 1 concentrates Boc-protected 4-hydroxy, 4S-hydroxy, and 3/4-hydroxymethyl entries—well suited for downstream functional-group interconversions and linker construction. |
Want to use reductive amination to quickly install substituents (using a ring ketone as the reaction center) | Table 1 or Table 2 | If you want the amine protected for cleaner reactions: choose N-Boc/N-Cbz ketones in Table 1. If you want to react directly from an amine salt: choose ketone hydrochloride salts in Table 2. |
Need more handleable amine salts / amino-acid salts (easier weighing, more controlled solubility/stability) for rapid library build-out or scale-up evaluation | Table 2 | Table 2 consolidates hydrochloride forms (ketone salts, 3/4-carboxylate salts) and unprotected 4-carboxylic acid, making it suitable for direct reaction entry or salt/solubility-window assessment. |
Need a dual-functional building block (amine + carboxylic acid): want to evaluate salt/buffer windows first, then decide whether to move to protected routes | Table 2 | Table 2 includes unprotected azepane-4-carboxylic acid and its carboxylic-acid hydrochloride salt, making it better for early scouting of salting behavior, solubility/stability, and charge-state windows. |
Need a basic seven-membered ring amine platform as a starting point (for quaternary salts/ionic derivatives, or as a general amine intermediate/acid scavenger) | Table 2 | Table 2 includes hexamethyleneimine (HMI)-type “parent amine platforms,” which are more direct starting points for substituted azepanes or for process/reaction feasibility checks. |
Materials/polymer work: need a lactam monomer, or want a lactam as an H-bond acceptor/solvation model substrate | Table 3 | Table 3 separately lists ε-caprolactam, a classic nylon-6 monomer and a common reference in materials and lactam-system studies. |
Need scaffold controls to compare: seven-membered azepane vs six-membered piperidine / sterically hindered piperidines in basicity, conformation, and ADME | Table 3 | Table 3 provides sterically hindered piperidine controls such as cis-2,6-dimethylpiperidine, suitable for “ring size/steric/conformation” comparison experiments. |
Unsure whether to run a protecting-group route or an HCl-salt route; want the fastest way to validate feasibility | Start with Table 2, then Table 1 | Rapid feasibility checks usually start with Table 2 (HCl salts/unprotected forms are more plug-and-play and allow immediate salting/solubility checks). After validation, return to Table 1 to choose the right protecting group and positional handle for systematic series building. |
Quick usage tips:
1. “Build structure-controlled series and systematic derivatization” → prioritize Table 1.
2. “Fast reaction entry / salt-form and handling operability” → prioritize Table 2.
3. “Materials monomers or ring-system comparators” → Table 3.
Table 1｜Boc/Cbz-Protected Azepane (Azacycloheptane) Building Blocks (Carboxylic Acids / Hydroxy / Hydroxymethyl / Cyclic Ketones) — Categorized by “Protecting Group + Reactive Handle”
Category | CAS No. | Aladdin Cat. No. | Name | Spec / Purity | Key features & applications |
Boc-protected | Azepane carboxylic acid (4-carboxy) | 868284-36-0 | 1-[((tert-Butoxy)carbonyl)]azepane-4-carboxylic acid | ≥97% | Seven-membered saturated N-heterocycle (azepane) + carboxylic-acid coupling handle: widely used for scaffold hopping in medicinal chemistry / increasing sp³ character; the carboxylic acid enables amidation and ring-fusion/linker connections; Boc protection facilitates subsequent deprotection to enable salt-form/property comparisons. | |
Boc-protected | Azepane carboxylic acid (3-carboxy) | 1252867-16-5 | 1-tert-Butoxycarbonylazepane-3-carboxylic acid | ≥97% | 3-carboxy positional isomer: used to build site-control pairs (3-position vs 4-position) to compare conformation/3D occupancy; carboxylic acid supports coupling; Boc enables downstream deprotection and salt-formation optimization. | |
Boc-protected | 4-hydroxy azepane | 478832-21-2 | tert-Butyl 4-hydroxyazepane-1-carboxylate | ≥97% | 4-hydroxy provides a derivatization entry (etherification/esterification/carbonate formation, etc.) to tune polarity and steric occupancy; Boc protection makes “functionalize first → deprotect/salt later” more controllable. | |
Boc-protected | 4-hydroxy azepane (chiral) | 1174020-38-2 | tert-Butyl (4S)-4-hydroxyazepane-1-carboxylate | ≥97% | Chiral 4S-hydroxy building block: enables stereochemical controls (enantiomer/configuration) and more refined 3D SAR; hydroxy supports further derivatization; Boc protection supports stepwise synthesis and later deprotection/salt formation. | |
Boc-protected | Hydroxymethyl azepane (4-position) | 1065608-51-6 | tert-Butyl 4-(hydroxymethyl)azepane-1-carboxylate | ≥97% | Alcohol handle intermediate: hydroxymethyl can be converted via halogenation/sulfonate ester formation/oxidation/etherification to install linkers or polar groups; Boc (tert-butyl carbamate) protection supports stepwise synthesis and later deprotection. | |
Boc-protected | Hydroxymethyl azepane (3-position) | 876147-43-2 | tert-Butyl 3-(hydroxymethyl)azepane-1-carboxylate | ≥97% | 3-hydroxymethyl “linker entry”: used to introduce side chains/polar groups or for downstream oxidation to aldehydes/acids; suitable for exploring 3-position substitution patterns and rapidly building series-based comparisons. | |
Boc-protected | Azepanone (4-one) | 188975-88-4 | N-Boc-hexahydro-1H-azepin-4-one | ≥98% | N-protected azepanone: reduces interference from the amine site and improves chemoselectivity; commonly used for carbonyl-centered transformations such as reductive amination/additions; subsequent Boc deprotection affords the target amine for salt-form/solubility optimization. | |
Cbz-protected | Azepanone (4-one) | 83621-33-4 | N-Cbz-4-azepanone | ≥97% | Cbz-protected version: suited for hydrogenolytic deprotection; useful when distinguishing protecting-group strategies from Boc conditions; likewise used for reductive amination/functionalization at the cyclic ketone to build substituted seven-membered N-heterocycles. |
Table 2｜Unprotected / Hydrochloride-Salt Azepane Platforms (Ketone Salts + Amino-Acid Salts + Parent Amine) — Categorized by “Physical Form / Handling Operability”
Category | CAS No. | Aladdin Cat. No. | Name | Spec / Purity | Key features & applications |
Azepanone (4-one) hydrochloride | amino ketone intermediate | 50492-22-3 | 4-Azepanone hydrochloride | ≥96% | The ring ketone handle is a high-frequency convertible site: commonly used to install substituents rapidly via reductive amination, enabling amine side-chain construction; the hydrochloride form improves weighing/handling and stability (as an amine-salt intermediate). | |
Azepanone (3-one) hydrochloride | amino ketone intermediate | 65326-54-7 | Azepan-3-one hydrochloride | ≥97% | 3-ketone amino-ketone salt: used for site controls (3-one vs 4-one) and exploration of different substitution patterns; typically taken downstream to 3-substituted azepane amines via reductive amination. | |
Azepane-4-carboxylic acid hydrochloride | amino-acid salt | 1393449-23-4 | Azepane-4-carboxylic acid; hydrochloride | ≥97% | 4-carboxy hydrochloride isomer: for conformation/3D occupancy comparisons; often used as a directly couplable “seven-membered N-heterocycle amino-acid” module, convenient for probing solubility/charge-state windows and in vivo exposure optimization. | |
Azepane-3-carboxylic acid hydrochloride | amino-acid salt | 2007916-48-3 | Azepane-3-carboxylic acid; hydrochloride | ≥97% | Dual-functional “amine salt + carboxylic acid” building block: hydrochloride enhances aqueous solubility and operability; carboxylic acid supports coupling (amidation/peptidomimetic linkages), useful in fragment libraries and lead optimization to explore polarity/salt-formation windows. | |
Unprotected | Azepane-4-carboxylic acid | 97164-96-0 | Azepane-4-carboxylic acid | ≥97% | Unprotected “amine + carboxylic acid” building block: convenient for direct salt formation and buffer-window evaluation; the acid supports coupling, while the amine site can be further substituted or salted with acids to improve solubility and formulation feasibility. | |
Parent amine | Hexamethyleneimine (Azepane/HMI) | 111-49-9 | H157403 | Hexamethyleneimine (HMI) | ≥98% (GC) | Foundational seven-membered ring amine platform: can serve as an organic base/acid scavenger or a general amine intermediate; used to prepare substituted azepanes and quaternary ammonium/ionic derivatives, offering a conformation/basicity window distinct from piperidine. |
Table 3｜Related / Control Platforms (Lactam Monomer + Piperidine Control) — Categorized by “Use Attribute”
Category | CAS No. | Aladdin Cat. No. | Name | Spec / Purity | Key features & applications |
Lactam monomer | ε-Caprolactam | 105-60-2 | Caprolactam (ε-caprolactam) | ≥99% | Representative materials monomer: key feedstock for nylon-6 (polyamide); also commonly used as a lactam/H-bond acceptor model substrate and as a starting point for polymer/materials-system studies. | |
Piperidine derivative | 2,6-dimethylpiperidine (cis) | 766-17-6 | cis-2,6-Dimethylpiperidine | ≥97% | 2,6-substitution introduces stronger steric hindrance and conformational differences: can be used as an amine/basic building block, acid scavenger, or a piperidine scaffold control; in lead optimization it is often used to evaluate how sterics/conformational changes affect potency and ADME. |
For more related articles, please see below: